{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-020569","form_type":"8-K","ticker":"FEED","cik":"0001326706","company_name":"ENvue Medical, Inc.","filed_at":"2025-07-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.677276+00:00","generated_at":"2026-05-18T04:10:07.873634+00:00","sec_items":["1.01","2.03","3.02","3.03","5.03"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"NanoVibronix raises $8M in private placement of Series H convertible preferred and warrants","bullets":["Initial closing of $8M gross proceeds: 8,889 Series H preferred shares ($1,000 stated value, convertible at $1.01/sh) and warrants for 4,678,363 shares at $2.25/sh.","Second closing of $2.22M (2,222 preferred shares) contingent on customary conditions.","Net proceeds: $5M to redeem Series X preferred stock; remainder for working capital.","Investor gets right to buy up to $44M additional preferred stock over 36 months at 85% of average VWAP.","Company must seek stockholder approval for issuance exceeding 19.99% of outstanding common stock."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-020569","json":"https://secwatch.observer/filing/0001641172-25-020569.json","markdown":"https://secwatch.observer/filing/0001641172-25-020569.md","text":"https://secwatch.observer/filing/0001641172-25-020569.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326706/000164117225020569/0001641172-25-020569-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326706/000164117225020569/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T04:10:07.873634+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}